Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals

被引:3
|
作者
Jiang, JD [1 ]
Bekesi, GJ [1 ]
机构
[1] Mt Sinai Sch Med, Div Med Oncol, New York, NY 10029 USA
关键词
antibody; HIV-1; homosexuals; immunophenotype; IVDU;
D O I
10.1016/S0753-3322(01)00065-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Immune responses to HIV-1 infection of 42 HIV-1-positive asymptomatic intravenous drug users (IVDUs) were compared with those of 135 HIV-1-infected asymptomatic homosexual men in the present study. Twenty-five HIV-1(-) individuals served as normal controls. The comparison included antibody responses to five computer-predicted epitopes of HIV-1 p17, and viral proteins gp120 and p24 as well as p17. Major immunophenotypes were also investigated. Results showed that antibody responses to the five epitopes were significantly higher in the IVDUs. A larger proportion of the IVDUs, with respect to that of homosexuals, showed positive antibody responses to p24 and p17, respectively. However, the antibody response to gp120 was similar between the two cohorts. Immunophenotyping showed that HIV-1(+) homosexuals had higher profiles in most of the major subsets than did the IVDUs, especially in the total count of lymphocytes, absolute numbers of CD3+ cells and CD8+ cells. It appeared that the HIV-1(+) IVDU cohort had higher antibody responses to most of the viral antigens, but had lower levels of lymphocyte subsets in comparison with HIV(+) homosexuals. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:313 / 315
页数:3
相关论文
共 50 条
  • [1] HIV-2 ANTIBODY REACTIVITY FOR HIV-1 ANTIGENS
    LILLO, F
    CAO, Y
    FERRO, A
    SABBATANI, S
    VARNIER, OE
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 251 - 251
  • [2] HIV-1 drug resistance in intravenous drug users undergoing seroconversion
    Wendel, K
    Quinn, TC
    Celis, L
    De Smet, K
    Hulstaert, F
    Shah, N
    Molijn, A
    Vlahov, D
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1210 - 1210
  • [3] HIV-1 infection in injection drug users
    Cohn, JA
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (03) : 745 - +
  • [4] RETROCELL HIV-1 PASSIVE HEMAGGLUTINATION ASSAY FOR HIV-1 ANTIBODY SCREENING
    SCHEFFEL, JW
    WIESNER, D
    KAPSALIS, A
    TRAYLOR, D
    SUAREZ, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (05): : 540 - 545
  • [5] A plant virus HIV-1 chimera stimulates antibody that neutralizes HIV-1
    McLain, L
    Durrani, Z
    Dimmock, NJ
    Wisniewski, LA
    Porta, C
    Lomonossoff, GP
    VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1996, : 311 - 316
  • [6] Perinatal HIV-1 infection in a child without HIV-1 antibody formation
    Moreno-Pérez, D
    Saiz, AG
    Martín, FJG
    Ortiz, AJ
    MEDICINA CLINICA, 2005, 125 (06): : 237 - 238
  • [7] Specific antibody responses to an HIV-1 vaccine
    Sands, AR
    Kent, SJ
    Dax, EM
    Johnson, EIM
    6TH EUROPEAN CONFERENCE ON EXPERIMENTAL AIDS RESEARCH, 2001, : 75 - 80
  • [8] Antibody responses in primary HIV-1 infection
    Frost, Simon D. W.
    Trkola, Alexandra
    Guenthard, Huldrych F.
    Richman, Douglas D.
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (01) : 45 - 51
  • [9] Neutralizing antibody responses to HIV-1 infection
    Morris, L
    IUBMB LIFE, 2002, 53 (4-5) : 197 - 199
  • [10] HIV-1 transmission and acute HIV-1 infection
    Hansasuta, P
    Rowland-Jones, SL
    BRITISH MEDICAL BULLETIN, 2001, 58 : 109 - 127